Skip to content
value.today
Surrozen, Inc./DE logo

Surrozen, Inc./DE

Surrozen, Inc./DE is listed today as Surrozen, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Surrozen, Inc./DE
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$76 MPrivate placement after listing$50 to $250 million

Surrozen, Inc./DE: Private sale, Mar 2025

Investors in this round

29 investors had bought by the notice of Apr 8, 2025: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$76 M of $175 M offered; $99 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: The Company issued to investors units, each consisting of one share of common stock, or pre-funded warrant in lieu thereof, and one half of a common stock warrant.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$4,584,137
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Williams · Executive Officer
  • Craig Parker · Executive Officer, Director
  • Yang J. Li, Ph.D. · Executive Officer
  • Anna J. Berkenblit, M.D. · Director
  • Christopher J. Chai · Director
  • David J. Woodhouse, Ph.D. · Director
  • Eric J. Bjerkholt · Director
  • Mace J. Rothenberg, M.D. · Director
  • Mary J. Haak-Frendscho, Ph.D. · Director
  • Shao-Lee J. Lin, M.D., Ph.D. · Director
  • Tim J. Kutzkey, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Guggenheim Securities, LLC (CRD 40638) · New York, New YorkSold in all US states

Signed by Charles O. Williams, Chief Financial Officer and COO. Source: SEC Form D, newest notice filed Apr 8, 2025. Read the notice at the SEC.

equity, optionsSEC
Apr 2024$193 MPrivate placement after listing$50 to $250 million

Surrozen, Inc./DE: Private sale, Apr 2024

Investors in this round

18 investors had bought by the notice of Apr 19, 2024: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$193 M of $193 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Williams · Executive Officer
  • Craig Parker · Executive Officer, Director
  • Anna J. Berkenblit, M.D. · Director
  • Christopher J. Chai · Director
  • David J. Woodhouse, Ph.D. · Director
  • Eric J. Bjerkholt · Director
  • Mace J. Rothenberg, M.D. · Director
  • Mary J. Haak-Frendscho, Ph.D. · Director
  • Shao-Lee J. Lin, M.D., Ph.D. · Director
  • Tim J. Kutzkey, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Guggenheim Securities, LLC (CRD 40638) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “The Total Offering Amount and Total Amount Sold include amounts that may be received by the Issuer upon exercise of the warrants.”

Signed by Charles O. Williams, Chief Financial Officer and COO. Source: SEC Form D, newest notice filed Apr 19, 2024. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Surrozen, Inc., its revenue in fiscal 2025 came from these product and service lines: Research service revenue $3.50 million (101%).

    Annual report (SEC XBRL) · Dec 2025

  • Surrozen, Inc./DE chose not to state its revenue in its newest notice of a funding round (Apr 2025).

    SEC Form D · Apr 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2025

Products and services#

No products or services of Surrozen, Inc./DE are on record.

Investors#

No investor of Surrozen, Inc./DE is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Surrozen, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Surrozen, Inc./DE
NameRoleNamed in
Charles WilliamsExecutive officerApr 2025
Craig ParkerExecutive officerApr 2025
Yang J. Li, Ph.D.Executive officerApr 2025
Anna J. Berkenblit, M.D.DirectorApr 2025
Christopher J. ChaiDirectorApr 2025
Craig ParkerDirectorApr 2025
David J. Woodhouse, Ph.D.DirectorApr 2025
Eric J. BjerkholtDirectorApr 2025
Mace J. Rothenberg, M.D.DirectorApr 2025
Mary J. Haak-Frendscho, Ph.D.DirectorApr 2025
Shao-Lee J. Lin, M.D., Ph.D.DirectorApr 2025
Tim J. Kutzkey, Ph.D.DirectorApr 2025

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.